Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a BCOR Internal Tandem Duplication

References

1. 1.↵
   1. Sturm D,
   2. Orr BA,
   3. Toprak UH, et al

   . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–72 doi:10.1016/j.cell.2016.01.015 pmid:26919435

   CrossRefPubMed
2. 2.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
3. 3.↵
   1. Kline CN,
   2. Joseph NM,
   3. Grenert JP, et al

   . Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol 2017;19:699–709 doi:10.1093/neuonc/now254 pmid:28453743

   CrossRefPubMed
4. 4.↵
   1. Paret C,
   2. Theruvath J,
   3. Russo A, et al

   . Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy. Oncotarget 2016;7:83378–91 doi:10.18632/oncotarget.13092 pmid:27825128

   CrossRefPubMed
5. 5.↵
   1. Appay R,
   2. Macagno N,
   3. Padovani L, et al

   . HGNET-BCOR tumors of the cerebellum. Am J Surg Pathol 2017;41:1254–60 doi:10.1097/PAS.0000000000000866 pmid:28704208

   CrossRefPubMed
6. 6.↵
   1. Yoshida Y,
   2. Nobusawa S,
   3. Nakata S, et al

   . CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Brain Pathol 2018;28:710–20 doi:10.1111/bpa.12585 pmid:29226988

   CrossRefPubMed
7. 7.↵
   1. Paret C,
   2. Russo A,
   3. Otto H, et al

   . Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. Oncotarget 2017;8:114210–25 doi:10.18632/oncotarget.23174 pmid:29371980

   CrossRefPubMed
8. 8.↵
   1. Al-Battashi A,
   2. Al Hajri Z,
   3. Perry A, et al

   . A cerebellar high-grade neuroepithelial tumour with BCOR alteration in a five-year-old child. Sultan Qaboos Univ Med J 2019;19:153–56 doi:10.18295/squmj.2019.19.02.012 pmid:31538015

   CrossRefPubMed
9. 9.↵
   1. Kirkman M,
   2. Pickles J,
   3. Fairchild A, et al

   . Early wound site seeding in a patient with central nervous system high-grade neuroepithelial tumor with BCOR alteration. World Neurosurg 2018;116:279–84 doi:10.1016/j.wneu.2018.05.158 pmid:29859355

   CrossRefPubMed
10. 10.↵
    1. Vewinger N,
    2. Huprich S,
    3. Seidmann L, et al

    . IGF1R is a potential new therapeutic target for HGNET-BCOR brain tumor patients. Int J Mol Sci 2019;20:3027 doi:10.3390/ijms20123027 pmid:31234291

    CrossRefPubMed
11. 11.↵
    1. Łastowska M,
    2. Trubicka J,
    3. Sobocińska A, et al

    . Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes. Acta Neuropathol Commun 2020;8:105 doi:10.1186/s40478-020-00984-9 pmid:32650833

    CrossRefPubMed
12. 12.↵
    1. Ferris S,
    2. Velazquez Vega J,
    3. Aboian M, et al

    . High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication: a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathol 2020;30:46–62 doi:10.1111/bpa.12747 pmid:31104347

    CrossRefPubMed
13. 13.↵
    1. Bremer J,
    2. Kottke R,
    3. Johann PD, et al

    . A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival. Pediatr Blood Cancer 2020;67:e28384 doi:10.1002/pbc.28384 pmid:32383815

    CrossRefPubMed
14. 14.↵
    1. Capper D,
    2. Jones DT,
    3. Sill M, et al

    . DNA methylation-based classification of central nervous system tumours. Nature 2018;555:469–74 doi:10.1038/nature26000 pmid:29539639

    CrossRefPubMed
15. 15.↵
    1. Astolfi A,
    2. Melchionda F,
    3. Perotti D, et al

    . Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. Oncotarget 2015;6:40934–39 doi:10.18632/oncotarget.5882 pmid:26516930

    CrossRefPubMed
16. 16.↵
    1. Roy A,
    2. Kumar V,
    3. Zorman B, et al

    . Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat Comm 2015;6:8891 doi:10.1038/ncomms9891 pmid:26573325

    CrossRefPubMed
17. 17.↵
    1. Ueno-Yokohata H,
    2. Okita H,
    3. Nakasato K, et al

    . Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. Nat Genet 2015;47:861–63 doi:10.1038/ng.3338 pmid:26098867

    CrossRefPubMed
18. 18.↵
    1. Kao YC,
    2. Sung YS,
    3. Zhang L, et al

    . Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol 2016;40:1009–20 doi:10.1097/PAS.0000000000000629 pmid:26945340

    CrossRefPubMed
19. 19.↵
    1. Santiago T,
    2. Clay MR,
    3. Allen SJ, et al

    . Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Mod Pathol 2018;31:374 doi:10.1038/modpathol.2017.178 pmid:29430000

    CrossRefPubMed
20. 20.↵
    1. Dangouloff-Ros V,
    2. Tauziède-Espariat A,
    3. Roux CJ, et al

    . CT and multimodal MR imaging features of embryonal tumors with multilayered rosettes in children. AJNR Am J Neuroradiol 2019;40:732–36 pmid:30846437

    Abstract/FREE Full Text
21. 21.↵
    1. Dangouloff-Ros V,
    2. Deroulers C,
    3. Foissac F, et al

    . Arterial spin labeling to predict brain tumor grading in children: correlations between histopathologic vascular density and perfusion MR imaging. Radiology 2016;281:553–66 doi:10.1148/radiol.2016152228 pmid:27257950

    CrossRefPubMed
22. 22.↵
    1. Jin B,
    2. Feng XY

    . MRI features of atypical teratoid/rhabdoid tumors in children. Pediatr Radiol 2013;43:1001–08 doi:10.1007/s00247-013-2646-9 pmid:23467756

    CrossRefPubMed
23. 23.↵
    1. Warmuth-Metz M,
    2. Bison B,
    3. Dannemann-Stern E, et al

    . CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology 2008;50:447–52 doi:10.1007/s00234-008-0369-7 pmid:18345534

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Meyers SP,
    2. Khademian ZP,
    3. Biegel JA, et al

    . Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol 2006;27:962–71 pmid:16687525

    PubMedWeb of Science
25. 25.↵
    1. Parmar H,
    2. Hawkins C,
    3. Bouffet E, et al

    . Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol 2006;36:126–32 doi:10.1007/s00247-005-0037-6 pmid:16341528

    CrossRefPubMed
26. 26.↵
    1. Zuccoli G,
    2. Izzi G,
    3. Bacchini E, et al

    . Central nervous system atypical teratoid/rhabdoid tumour of infancy. CT and MR findings. Clin Imaging 1999;23:356–60 doi:10.1016/S0899-7071(99)00165-5 pmid:10899417

    CrossRefPubMed
27. 27.↵
    1. Alrayahi J,
    2. Zapotocky M,
    3. Ramaswamy V, et al

    . Pediatric brain tumor genetics: what radiologists need to know. Radiographics 2018;38:2102–22 doi:10.1148/rg.2018180109 pmid:30422762

    CrossRefPubMed
28. 28.↵
    1. Northcott PA,
    2. Korshunov A,
    3. Witt H, et al

    . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011;29:1408–14 doi:10.1200/JCO.2009.27.4324 pmid:20823417

    Abstract/FREE Full Text
29. 29.↵
    1. Mata-Mbemba D,
    2. Zapotcky M,
    3. Laughlin S, et al

    . MRI characteristics of primary tumors and metastatic lesions in molecular subgroups of pediatric medulloblastoma: a single-center study. AJNR Am J Neuroradiol 2018;39:949–55 doi:10.3174/ajnr.A5578 pmid:29545246

    Abstract/FREE Full Text
30. 30.↵
    1. Yuh EL,
    2. Barkovich AJ,
    3. Gupta N

    . Imaging of ependymomas: MRI and CT. Childs Nerv Syst 2009;25:1203–13 doi:10.1007/s00381-009-0878-7 pmid:19360419

    CrossRefPubMedWeb of Science